Cardiomyopathy (Heart Muscle Disease) Therapeutics Clinical Trials Market 2014 Analysis in a New Report Available at MarketOptimizer.org
Dallas, Texas (PRWEB) August 23, 2014 -- Cardiomyopathy (heart muscle disease) is the measurable deterioration of the function of the myocardium (the heart muscle) for any reason, usually leading to heart failure; common symptoms are dyspnea (breathlessness) and peripheral edema (swelling of the legs). People with cardiomyopathy are often at risk of dangerous forms of irregular heart beat and sudden cardiac death. The most common form of cardiomyopathy is dilated cardiomyopathy.
Clinical trial report, “Cardiomyopathy Global Clinical Trials Review, H2, 2014″ provides data on the Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cardiomyopathy.
Complete report details at http://www.marketoptimizer.org/cardiomyopathy-global-clinical-trials-review-h2-2014.html .
Scope
• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Order a purchase copy at http://www.marketoptimizer.org/contacts/purchase?rname=9647 .
(This is a premium report priced at US$2500 for a single user License and US $7500 for Corporate User License)
Major Table of Contents for This Report
Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Cardiomyopathy
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Cardiomyopathy to Cardiovascular Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Cardiomyopathy to Cardiovascular Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Cardiomyopathy
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Cardiomyopathy Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Gilead Sciences, Inc.
Clinical Trial Overview of Gilead Sciences, Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Les Laboratoires Servier SAS
Clinical Trial Overview of Les Laboratoires Servier SAS
Celladon Corporation
Clinical Trial Overview of Celladon Corporation
Aastrom Biosciences, Inc.
Clinical Trial Overview of Aastrom Biosciences, Inc.
Bayer AG
Clinical Trial Overview of Bayer AG
Array BioPharma Inc.
Clinical Trial Overview of Array BioPharma Inc.
AAVLife
Clinical Trial Overview of AAVLife
A. Menarini Industrie Farmaceutiche Riunite Srl
Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl
Clinical Trial Overview of Top Institutes / Government
National Heart, Lung, and Blood Institute
Clinical Trial Overview of National Heart, Lung, and Blood Institute
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
Johns Hopkins University
Clinical Trial Overview of Johns Hopkins University
Assistance Publique – Hopitaux de Paris
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris
University of Michigan
Clinical Trial Overview of University of Michigan
Osaka University
Clinical Trial Overview of Osaka University
Maastricht University Medical Center
Clinical Trial Overview of Maastricht University Medical Center
University Health Network
Clinical Trial Overview of University Health Network
Johann Wolfgang Goethe University Hospitals
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals
Stanford University
Clinical Trial Overview of Stanford University
Five Key Clinical Profiles
Explore more reports on Pharmaceuticals industry at http://www.marketoptimizer.org/category/energy-power/energy.
About Us:
MarketOptimizer.org is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Ritesh Tiwari, MarketOptimizer, http://www.marketoptimizer.org/, +1 (888) 391-5441, [email protected]
Share this article